Fetroja (cefiderocol sulfate tosylate) NDC 59630-266

NDC codes

FDA NDC Directory

Product NDC (as listed)59630-266Labeler and product segments. Claims need a package NDC.

Product NDC at billing width59630-0266Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
59630-266-10	59630026610	10 VIAL, SINGLE-USE in 1 CARTON (59630-266-10) / 10 mL in 1 VIAL, SINGLE-USE (59630-266-01)Marketed from Jan 31, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Fetroja
Generic name (nonproprietary): cefiderocol sulfate tosylate
Active ingredients: Cefiderocol sulfate tosylate — 1 g/10mL
Dosage form: Injection, Powder, For solution
Route: Intravenous
Labeler: Shionogi Inc.
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 209445
Marketing start: Jan 31, 2020
Listing expires: Dec 31, 2027
Other FDA classes: Cephalosporins (Chemical structure)
Identifiers: Product ID 59630-266_64c35e73-1daa-4a82-a3c2-a737dec6eeaeSPL ID 64c35e73-1daa-4a82-a3c2-a737dec6eeaeSPL set ID 75c0c785-38e0-4049-a6fb-b77581f5b35cRxCUI 2265706, 2265711UNII TTP8LBP45D
Pharmacologic class: Cephalosporin Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N459630026610 followed by a unit qualifier and the quantity

Package 59630-0266-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 24, 2026.

Indications (excerpt from the label)

FETROJA is a cephalosporin antibacterial indicated in patients 18 years of age or older for the treatment of the following infections caused by susceptible Gram-negative microorganisms: Complicated Urinary Tract Infections (cUTI), including Pyelonephritis ( 1.1 ) Hospital-acquired Bacterial Pneumonia and Ventilator-associated Bacterial Pneumonia (HABP/VABP) ( 1.2 ) To reduce the development of drug-resistant bacteria and maintain the effectiveness of FETROJA and other antibacterial drugs, FETROJA should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. ( 1.3 ) 1.1 Complicated Urinary Tract Infections (cUTIs), Including Pyelonephritis …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)